0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-28F11903
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Diabetes Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-28F11903
Report
September 2022
134 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Diabetes Drugs market is projected to reach US$ 78200 million by 2028 from an estimated US$ 56710 million in 2022, at a CAGR of 5.5% during 2023 and 2028.

Global Diabetes Drugs key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share over 30%.
In terms of product, Insulin is the largest segment, with a share over 45%. And in terms of application, the largest application is Type 1 Diabetes, followed by Type 2.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Diabetes Drugs.
The Diabetes Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Diabetes Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Sanofi
AstraZeneca
Bayer
Biocon
Boehringer Ingelheim
Dongbao Pharmaceutical
Eli Lilly
Ganlee
Ginwa
Guangzhou Baiyun Mountain
Hisun Pharmacy
Hua Dong
Huadong Medicine
Jumpcan Pharmacy
KELUN
Merck & Co.
MSD
North China Pharmaceutical Group Corporation
Novartis
Novo Nordisk
Sanofi
SHIJIAZHUANG YILING PHARMACEUTICAL
Takeda
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals
Product Type Insights
Global markets are presented by Diabetes Drugs type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Diabetes Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Diabetes Drugs Segment by Type

Insulin
DPP-4
GLP-1
SGLT-2
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Diabetes Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Diabetes Drugs market.

Diabetes Drugs Segment by Application

Type 1 Diabetes
Type 2 Diabetes
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Diabetes Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetes Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Diabetes Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Diabetes Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetes Drugs

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Diabetes Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Diabetes Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Insulin
1.2.3 DPP-4
1.2.4 GLP-1
1.2.5 SGLT-2
1.3 Market by Application
1.3.1 Global Diabetes Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diabetes Drugs Market Size Estimates and Forecasts
2.1.1 Global Diabetes Drugs Revenue 2017-2028
2.1.2 Global Diabetes Drugs Sales 2017-2028
2.2 Diabetes Drugs Market Size by Region: 2022 Versus 2028
2.3 Diabetes Drugs Sales by Region (2017-2028)
2.3.1 Global Diabetes Drugs Sales by Region: 2017-2022
2.3.2 Global Diabetes Drugs Sales Forecast by Region (2023-2028)
2.3.3 Global Diabetes Drugs Sales Market Share by Region (2017-2028)
2.4 Diabetes Drugs Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Diabetes Drugs Revenue by Region: 2017-2022
2.4.2 Global Diabetes Drugs Revenue Forecast by Region (2023-2028)
2.4.3 Global Diabetes Drugs Revenue Market Share by Region (2017-2028)
3 Global Diabetes Drugs by Manufacturers
3.1 Global Top Diabetes Drugs Manufacturers by Sales
3.1.1 Global Diabetes Drugs Sales by Manufacturer (2017-2022)
3.1.2 Global Diabetes Drugs Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Diabetes Drugs Manufacturers by Revenue
3.2.1 Global Diabetes Drugs Revenue by Manufacturer (2017-2022)
3.2.2 Global Diabetes Drugs Revenue Share by Manufacturer (2017-2022)
3.3 Global Diabetes Drugs Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Diabetes Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Diabetes Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Diabetes Drugs Manufacturing Base Distribution, Product Type
3.5.1 Diabetes Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Diabetes Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Diabetes Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi
4.1.1 Sanofi Corporation Information
4.1.2 Sanofi Description, Business Overview
4.1.3 Sanofi Diabetes Drugs Products Offered
4.1.4 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Sanofi Diabetes Drugs Sales by Product in 2021
4.1.6 Sanofi Diabetes Drugs Sales by Application in 2021
4.1.7 Sanofi Diabetes Drugs Sales by Geographic Area in 2021
4.1.8 Sanofi Recent Developments
4.2 AstraZeneca
4.2.1 AstraZeneca Corporation Information
4.2.2 AstraZeneca Description, Business Overview
4.2.3 AstraZeneca Diabetes Drugs Products Offered
4.2.4 AstraZeneca Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.2.5 AstraZeneca Diabetes Drugs Sales by Product in 2021
4.2.6 AstraZeneca Diabetes Drugs Sales by Application in 2021
4.2.7 AstraZeneca Diabetes Drugs Sales by Geographic Area in 2021
4.2.8 AstraZeneca Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Diabetes Drugs Products Offered
4.3.4 Bayer Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Diabetes Drugs Sales by Product in 2021
4.3.6 Bayer Diabetes Drugs Sales by Application in 2021
4.3.7 Bayer Diabetes Drugs Sales by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 Biocon
4.4.1 Biocon Corporation Information
4.4.2 Biocon Description, Business Overview
4.4.3 Biocon Diabetes Drugs Products Offered
4.4.4 Biocon Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Biocon Diabetes Drugs Sales by Product in 2021
4.4.6 Biocon Diabetes Drugs Sales by Application in 2021
4.4.7 Biocon Diabetes Drugs Sales by Geographic Area in 2021
4.4.8 Biocon Recent Developments
4.5 Boehringer Ingelheim
4.5.1 Boehringer Ingelheim Corporation Information
4.5.2 Boehringer Ingelheim Description, Business Overview
4.5.3 Boehringer Ingelheim Diabetes Drugs Products Offered
4.5.4 Boehringer Ingelheim Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Boehringer Ingelheim Diabetes Drugs Sales by Product in 2021
4.5.6 Boehringer Ingelheim Diabetes Drugs Sales by Application in 2021
4.5.7 Boehringer Ingelheim Diabetes Drugs Sales by Geographic Area in 2021
4.5.8 Boehringer Ingelheim Recent Developments
4.6 Dongbao Pharmaceutical
4.6.1 Dongbao Pharmaceutical Corporation Information
4.6.2 Dongbao Pharmaceutical Description, Business Overview
4.6.3 Dongbao Pharmaceutical Diabetes Drugs Products Offered
4.6.4 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Dongbao Pharmaceutical Diabetes Drugs Sales by Product in 2021
4.6.6 Dongbao Pharmaceutical Diabetes Drugs Sales by Application in 2021
4.6.7 Dongbao Pharmaceutical Diabetes Drugs Sales by Geographic Area in 2021
4.6.8 Dongbao Pharmaceutical Recent Development
4.7 Eli Lilly
4.7.1 Eli Lilly Corporation Information
4.7.2 Eli Lilly Description, Business Overview
4.7.3 Eli Lilly Diabetes Drugs Products Offered
4.7.4 Eli Lilly Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Eli Lilly Diabetes Drugs Sales by Product in 2021
4.7.6 Eli Lilly Diabetes Drugs Sales by Application in 2021
4.7.7 Eli Lilly Diabetes Drugs Sales by Geographic Area in 2021
4.7.8 Eli Lilly Recent Development
4.8 Ganlee
4.8.1 Ganlee Corporation Information
4.8.2 Ganlee Description, Business Overview
4.8.3 Ganlee Diabetes Drugs Products Offered
4.8.4 Ganlee Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Ganlee Diabetes Drugs Sales by Product in 2021
4.8.6 Ganlee Diabetes Drugs Sales by Application in 2021
4.8.7 Ganlee Diabetes Drugs Sales by Geographic Area in 2021
4.8.8 Ganlee Recent Development
4.9 Ginwa
4.9.1 Ginwa Corporation Information
4.9.2 Ginwa Description, Business Overview
4.9.3 Ginwa Diabetes Drugs Products Offered
4.9.4 Ginwa Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Ginwa Diabetes Drugs Sales by Product in 2021
4.9.6 Ginwa Diabetes Drugs Sales by Application in 2021
4.9.7 Ginwa Diabetes Drugs Sales by Geographic Area in 2021
4.9.8 Ginwa Recent Development
4.10 Guangzhou Baiyun Mountain
4.10.1 Guangzhou Baiyun Mountain Corporation Information
4.10.2 Guangzhou Baiyun Mountain Description, Business Overview
4.10.3 Guangzhou Baiyun Mountain Diabetes Drugs Products Offered
4.10.4 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Guangzhou Baiyun Mountain Diabetes Drugs Sales by Product in 2021
4.10.6 Guangzhou Baiyun Mountain Diabetes Drugs Sales by Application in 2021
4.10.7 Guangzhou Baiyun Mountain Diabetes Drugs Sales by Geographic Area in 2021
4.10.8 Guangzhou Baiyun Mountain Recent Development
4.11 Hisun Pharmacy
4.11.1 Hisun Pharmacy Corporation Information
4.11.2 Hisun Pharmacy Description, Business Overview
4.11.3 Hisun Pharmacy Diabetes Drugs Products Offered
4.11.4 Hisun Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Hisun Pharmacy Diabetes Drugs Sales by Product in 2021
4.11.6 Hisun Pharmacy Diabetes Drugs Sales by Application in 2021
4.11.7 Hisun Pharmacy Diabetes Drugs Sales by Geographic Area in 2021
4.11.8 Hisun Pharmacy Recent Development
4.12 Hua Dong
4.12.1 Hua Dong Corporation Information
4.12.2 Hua Dong Description, Business Overview
4.12.3 Hua Dong Diabetes Drugs Products Offered
4.12.4 Hua Dong Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Hua Dong Diabetes Drugs Sales by Product in 2021
4.12.6 Hua Dong Diabetes Drugs Sales by Application in 2021
4.12.7 Hua Dong Diabetes Drugs Sales by Geographic Area in 2021
4.12.8 Hua Dong Recent Development
4.13 Huadong Medicine
4.13.1 Huadong Medicine Corporation Information
4.13.2 Huadong Medicine Description, Business Overview
4.13.3 Huadong Medicine Diabetes Drugs Products Offered
4.13.4 Huadong Medicine Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Huadong Medicine Diabetes Drugs Sales by Product in 2021
4.13.6 Huadong Medicine Diabetes Drugs Sales by Application in 2021
4.13.7 Huadong Medicine Diabetes Drugs Sales by Geographic Area in 2021
4.13.8 Huadong Medicine Recent Development
4.14 Jumpcan Pharmacy
4.14.1 Jumpcan Pharmacy Corporation Information
4.14.2 Jumpcan Pharmacy Description, Business Overview
4.14.3 Jumpcan Pharmacy Diabetes Drugs Products Offered
4.14.4 Jumpcan Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Jumpcan Pharmacy Diabetes Drugs Sales by Product in 2021
4.14.6 Jumpcan Pharmacy Diabetes Drugs Sales by Application in 2021
4.14.7 Jumpcan Pharmacy Diabetes Drugs Sales by Geographic Area in 2021
4.14.8 Jumpcan Pharmacy Recent Development
4.15 KELUN
4.15.1 KELUN Corporation Information
4.15.2 KELUN Description, Business Overview
4.15.3 KELUN Diabetes Drugs Products Offered
4.15.4 KELUN Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.15.5 KELUN Diabetes Drugs Sales by Product in 2021
4.15.6 KELUN Diabetes Drugs Sales by Application in 2021
4.15.7 KELUN Diabetes Drugs Sales by Geographic Area in 2021
4.15.8 KELUN Recent Development
4.16 Merck & Co.
4.16.1 Merck & Co. Corporation Information
4.16.2 Merck & Co. Description, Business Overview
4.16.3 Merck & Co. Diabetes Drugs Products Offered
4.16.4 Merck & Co. Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Merck & Co. Diabetes Drugs Sales by Product in 2021
4.16.6 Merck & Co. Diabetes Drugs Sales by Application in 2021
4.16.7 Merck & Co. Diabetes Drugs Sales by Geographic Area in 2021
4.16.8 Merck & Co. Recent Development
4.17 MSD
4.17.1 MSD Corporation Information
4.17.2 MSD Description, Business Overview
4.17.3 MSD Diabetes Drugs Products Offered
4.17.4 MSD Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.17.5 MSD Diabetes Drugs Sales by Product in 2021
4.17.6 MSD Diabetes Drugs Sales by Application in 2021
4.17.7 MSD Diabetes Drugs Sales by Geographic Area in 2021
4.17.8 MSD Recent Development
4.18 North China Pharmaceutical Group Corporation
4.18.1 North China Pharmaceutical Group Corporation Corporation Information
4.18.2 North China Pharmaceutical Group Corporation Description, Business Overview
4.18.3 North China Pharmaceutical Group Corporation Diabetes Drugs Products Offered
4.18.4 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.18.5 North China Pharmaceutical Group Corporation Diabetes Drugs Sales by Product in 2021
4.18.6 North China Pharmaceutical Group Corporation Diabetes Drugs Sales by Application in 2021
4.18.7 North China Pharmaceutical Group Corporation Diabetes Drugs Sales by Geographic Area in 2021
4.18.8 North China Pharmaceutical Group Corporation Recent Development
4.19 Novartis
4.19.1 Novartis Corporation Information
4.19.2 Novartis Description, Business Overview
4.19.3 Novartis Diabetes Drugs Products Offered
4.19.4 Novartis Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.19.5 Novartis Diabetes Drugs Sales by Product in 2021
4.19.6 Novartis Diabetes Drugs Sales by Application in 2021
4.19.7 Novartis Diabetes Drugs Sales by Geographic Area in 2021
4.19.8 Novartis Recent Development
4.20 Novo Nordisk
4.20.1 Novo Nordisk Corporation Information
4.20.2 Novo Nordisk Description, Business Overview
4.20.3 Novo Nordisk Diabetes Drugs Products Offered
4.20.4 Novo Nordisk Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.20.5 Novo Nordisk Diabetes Drugs Sales by Product in 2021
4.20.6 Novo Nordisk Diabetes Drugs Sales by Application in 2021
4.20.7 Novo Nordisk Diabetes Drugs Sales by Geographic Area in 2021
4.20.8 Novo Nordisk Recent Development
4.21 Sanofi
4.21.1 Sanofi Corporation Information
4.21.2 Sanofi Description, Business Overview
4.21.3 Sanofi Diabetes Drugs Products Offered
4.21.4 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.21.5 Sanofi Diabetes Drugs Sales by Product in 2021
4.21.6 Sanofi Diabetes Drugs Sales by Application in 2021
4.21.7 Sanofi Diabetes Drugs Sales by Geographic Area in 2021
4.21.8 Sanofi Recent Development
4.22 SHIJIAZHUANG YILING PHARMACEUTICAL
4.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
4.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Description, Business Overview
4.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Products Offered
4.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales by Product in 2021
4.22.6 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales by Application in 2021
4.22.7 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales by Geographic Area in 2021
4.22.8 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
4.23 Takeda
4.23.1 Takeda Corporation Information
4.23.2 Takeda Description, Business Overview
4.23.3 Takeda Diabetes Drugs Products Offered
4.23.4 Takeda Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.23.5 Takeda Diabetes Drugs Sales by Product in 2021
4.23.6 Takeda Diabetes Drugs Sales by Application in 2021
4.23.7 Takeda Diabetes Drugs Sales by Geographic Area in 2021
4.23.8 Takeda Recent Development
4.24 Taloph
4.24.1 Taloph Corporation Information
4.24.2 Taloph Description, Business Overview
4.24.3 Taloph Diabetes Drugs Products Offered
4.24.4 Taloph Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.24.5 Taloph Diabetes Drugs Sales by Product in 2021
4.24.6 Taloph Diabetes Drugs Sales by Application in 2021
4.24.7 Taloph Diabetes Drugs Sales by Geographic Area in 2021
4.24.8 Taloph Recent Development
4.25 Tianan Pharmaceutical
4.25.1 Tianan Pharmaceutical Corporation Information
4.25.2 Tianan Pharmaceutical Description, Business Overview
4.25.3 Tianan Pharmaceutical Diabetes Drugs Products Offered
4.25.4 Tianan Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.25.5 Tianan Pharmaceutical Diabetes Drugs Sales by Product in 2021
4.25.6 Tianan Pharmaceutical Diabetes Drugs Sales by Application in 2021
4.25.7 Tianan Pharmaceutical Diabetes Drugs Sales by Geographic Area in 2021
4.25.8 Tianan Pharmaceutical Recent Development
4.26 Tonghua DongBao
4.26.1 Tonghua DongBao Corporation Information
4.26.2 Tonghua DongBao Description, Business Overview
4.26.3 Tonghua DongBao Diabetes Drugs Products Offered
4.26.4 Tonghua DongBao Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.26.5 Tonghua DongBao Diabetes Drugs Sales by Product in 2021
4.26.6 Tonghua DongBao Diabetes Drugs Sales by Application in 2021
4.26.7 Tonghua DongBao Diabetes Drugs Sales by Geographic Area in 2021
4.26.8 Tonghua DongBao Recent Development
4.27 Wanbang Biopharmaceuticals
4.27.1 Wanbang Biopharmaceuticals Corporation Information
4.27.2 Wanbang Biopharmaceuticals Description, Business Overview
4.27.3 Wanbang Biopharmaceuticals Diabetes Drugs Products Offered
4.27.4 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Revenue and Gross Margin (2017-2022)
4.27.5 Wanbang Biopharmaceuticals Diabetes Drugs Sales by Product in 2021
4.27.6 Wanbang Biopharmaceuticals Diabetes Drugs Sales by Application in 2021
4.27.7 Wanbang Biopharmaceuticals Diabetes Drugs Sales by Geographic Area in 2021
4.27.8 Wanbang Biopharmaceuticals Recent Development
5 Breakdown Data by Type
5.1 Global Diabetes Drugs Sales by Type (2017-2028)
5.1.1 Global Diabetes Drugs Sales by Type (2017-2022)
5.1.2 Global Diabetes Drugs Sales Forecast by Type (2023-2028)
5.1.3 Global Diabetes Drugs Sales Market Share by Type (2017-2028)
5.2 Global Diabetes Drugs Revenue Forecast by Type (2017-2028)
5.2.1 Global Diabetes Drugs Revenue by Type (2017-2022)
5.2.2 Global Diabetes Drugs Revenue Forecast by Type (2023-2028)
5.2.3 Global Diabetes Drugs Revenue Market Share by Type (2017-2028)
5.3 Diabetes Drugs Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Diabetes Drugs Sales by Application (2017-2028)
6.1.1 Global Diabetes Drugs Sales by Application (2017-2022)
6.1.2 Global Diabetes Drugs Sales Forecast by Application (2023-2028)
6.1.3 Global Diabetes Drugs Sales Market Share by Application (2017-2028)
6.2 Global Diabetes Drugs Revenue Forecast by Application (2017-2028)
6.2.1 Global Diabetes Drugs Revenue by Application (2017-2022)
6.2.2 Global Diabetes Drugs Revenue Forecast by Application (2023-2028)
6.2.3 Global Diabetes Drugs Revenue Market Share by Application (2017-2028)
6.3 Diabetes Drugs Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Diabetes Drugs Market Size YoY Growth 2017-2028
7.2 North America Diabetes Drugs Market Facts & Figures by Country
7.2.1 North America Diabetes Drugs Sales by Country (2017-2028)
7.2.2 North America Diabetes Drugs Revenue by Country (2017-2028)
7.3 North America Diabetes Drugs Sales by Type
7.4 North America Diabetes Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Diabetes Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific Diabetes Drugs Sales by Region (2017-2028)
8.2.2 Asia-Pacific Diabetes Drugs Revenue by Region (2017-2028)
8.3 Asia-Pacific Diabetes Drugs Sales by Type
8.4 Asia-Pacific Diabetes Drugs Sales by Application
9 Europe
9.1 Europe Diabetes Drugs Market Size YoY Growth 2017-2028
9.2 Europe Diabetes Drugs Market Facts & Figures by Country
9.2.1 Europe Diabetes Drugs Sales by Country (2017-2028)
9.2.2 Europe Diabetes Drugs Revenue by Country (2017-2028)
9.3 Europe Diabetes Drugs Sales by Type
9.4 Europe Diabetes Drugs Sales by Application
10 Latin America
10.1 Latin America Diabetes Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Diabetes Drugs Market Facts & Figures by Country
10.2.1 Latin America Diabetes Drugs Sales by Country (2017-2028)
10.2.2 Latin America Diabetes Drugs Revenue by Country (2017-2028)
10.3 Latin America Diabetes Drugs Sales by Type
10.4 Latin America Diabetes Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Diabetes Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Diabetes Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Diabetes Drugs Sales by Country (2017-2028)
11.2.2 Middle East and Africa Diabetes Drugs Revenue by Country (2017-2028)
11.3 Middle East and Africa Diabetes Drugs Sales by Type
11.4 Middle East and Africa Diabetes Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Diabetes Drugs Supply Chain Analysis
12.2 Diabetes Drugs Key Raw Materials and Upstream Suppliers
12.3 Diabetes Drugs Clients Analysis
12.4 Diabetes Drugs Sales Channel and Sales Model Analysis
12.4.1 Diabetes Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Diabetes Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Diabetes Drugs Distributors
13 Market Dynamics
13.1 Diabetes Drugs Industry Trends
13.2 Diabetes Drugs Market Drivers
13.3 Diabetes Drugs Market Challenges
13.4 Diabetes Drugs Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Diabetes Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Insulin
    Table 3. Major Manufacturers of DPP-4
    Table 4. Major Manufacturers of GLP-1
    Table 5. Major Manufacturers of SGLT-2
    Table 6. Global Diabetes Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Diabetes Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 8. Global Diabetes Drugs Sales by Region (2017-2022) & (M Units)
    Table 9. Global Diabetes Drugs Sales Forecast by Region (2023-2028) & (M Units)
    Table 10. Global Diabetes Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Diabetes Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 12. Global Diabetes Drugs Sales by Manufacturer (2017-2022) & (M Units)
    Table 13. Global Diabetes Drugs Sales Share by Manufacturer (2017-2022)
    Table 14. Diabetes Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 15. Diabetes Drugs Revenue Share by Manufacturer (2017-2022)
    Table 16. Key Manufacturers Diabetes Drugs Price (2017-2022) & (USD/Unit)
    Table 17. Ranking of Global Top Diabetes Drugs Manufacturers by Revenue (US$ Million) in 2021
    Table 18. Global Diabetes Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 19. Global Diabetes Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drugs as of 2021)
    Table 20. Diabetes Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Diabetes Drugs Product Type
    Table 22. Date of International Manufacturers Enter into Diabetes Drugs Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. Sanofi Corporation Information
    Table 25. Sanofi Description and Business Overview
    Table 26. Sanofi Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 27. Sanofi Diabetes Drugs Product
    Table 28. Sanofi Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 29. Sanofi Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 30. Sanofi Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 31. Sanofi Recent Development
    Table 32. AstraZeneca Corporation Information
    Table 33. AstraZeneca Description and Business Overview
    Table 34. AstraZeneca Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 35. AstraZeneca Diabetes Drugs Product
    Table 36. AstraZeneca Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 37. AstraZeneca Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 38. AstraZeneca Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 39. AstraZeneca Recent Development
    Table 40. Bayer Corporation Information
    Table 41. Bayer Description and Business Overview
    Table 42. Bayer Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 43. Bayer Diabetes Drugs Product
    Table 44. Bayer Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 45. Bayer Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 46. Bayer Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 47. Bayer Recent Development
    Table 48. Biocon Corporation Information
    Table 49. Biocon Description and Business Overview
    Table 50. Biocon Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 51. Biocon Diabetes Drugs Product
    Table 52. Biocon Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 53. Biocon Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 54. Biocon Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 55. Biocon Recent Development
    Table 56. Boehringer Ingelheim Corporation Information
    Table 57. Boehringer Ingelheim Description and Business Overview
    Table 58. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 59. Boehringer Ingelheim Diabetes Drugs Product
    Table 60. Boehringer Ingelheim Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 61. Boehringer Ingelheim Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 62. Boehringer Ingelheim Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 63. Boehringer Ingelheim Recent Development
    Table 64. Dongbao Pharmaceutical Corporation Information
    Table 65. Dongbao Pharmaceutical Description and Business Overview
    Table 66. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Dongbao Pharmaceutical Diabetes Drugs Product
    Table 68. Dongbao Pharmaceutical Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 69. Dongbao Pharmaceutical Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 70. Dongbao Pharmaceutical Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 71. Eli Lilly Corporation Information
    Table 72. Eli Lilly Description and Business Overview
    Table 73. Eli Lilly Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 74. Eli Lilly Diabetes Drugs Product
    Table 75. Eli Lilly Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 76. Eli Lilly Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 77. Eli Lilly Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 78. Ganlee Corporation Information
    Table 79. Ganlee Description and Business Overview
    Table 80. Ganlee Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 81. Ganlee Diabetes Drugs Product
    Table 82. Ganlee Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 83. Ganlee Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 84. Ganlee Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 85. Ginwa Corporation Information
    Table 86. Ginwa Description and Business Overview
    Table 87. Ginwa Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 88. Ginwa Diabetes Drugs Product
    Table 89. Ginwa Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 90. Ginwa Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 91. Ginwa Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 92. Guangzhou Baiyun Mountain Corporation Information
    Table 93. Guangzhou Baiyun Mountain Description and Business Overview
    Table 94. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Guangzhou Baiyun Mountain Diabetes Drugs Product
    Table 96. Guangzhou Baiyun Mountain Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 97. Guangzhou Baiyun Mountain Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 98. Guangzhou Baiyun Mountain Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 99. Hisun Pharmacy Corporation Information
    Table 100. Hisun Pharmacy Description and Business Overview
    Table 101. Hisun Pharmacy Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Hisun Pharmacy Diabetes Drugs Product
    Table 103. Hisun Pharmacy Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 104. Hisun Pharmacy Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 105. Hisun Pharmacy Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 106. Hua Dong Corporation Information
    Table 107. Hua Dong Description and Business Overview
    Table 108. Hua Dong Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Hua Dong Diabetes Drugs Product
    Table 110. Hua Dong Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 111. Hua Dong Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 112. Hua Dong Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 113. Huadong Medicine Corporation Information
    Table 114. Huadong Medicine Description and Business Overview
    Table 115. Huadong Medicine Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Huadong Medicine Diabetes Drugs Product
    Table 117. Huadong Medicine Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 118. Huadong Medicine Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 119. Huadong Medicine Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 120. Jumpcan Pharmacy Corporation Information
    Table 121. Jumpcan Pharmacy Description and Business Overview
    Table 122. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Jumpcan Pharmacy Diabetes Drugs Product
    Table 124. Jumpcan Pharmacy Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 125. Jumpcan Pharmacy Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 126. Jumpcan Pharmacy Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 127. KELUN Corporation Information
    Table 128. KELUN Description and Business Overview
    Table 129. KELUN Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. KELUN Diabetes Drugs Product
    Table 131. KELUN Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 132. KELUN Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 133. KELUN Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 134. Merck & Co. Corporation Information
    Table 135. Merck & Co. Description and Business Overview
    Table 136. Merck & Co. Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Merck & Co. Diabetes Drugs Product
    Table 138. Merck & Co. Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 139. Merck & Co. Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 140. Merck & Co. Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 141. MSD Corporation Information
    Table 142. MSD Description and Business Overview
    Table 143. MSD Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. MSD Diabetes Drugs Product
    Table 145. MSD Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 146. MSD Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 147. MSD Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 148. North China Pharmaceutical Group Corporation Corporation Information
    Table 149. North China Pharmaceutical Group Corporation Description and Business Overview
    Table 150. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. North China Pharmaceutical Group Corporation Diabetes Drugs Product
    Table 152. North China Pharmaceutical Group Corporation Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 153. North China Pharmaceutical Group Corporation Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 154. North China Pharmaceutical Group Corporation Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 155. Novartis Corporation Information
    Table 156. Novartis Description and Business Overview
    Table 157. Novartis Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Novartis Diabetes Drugs Product
    Table 159. Novartis Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 160. Novartis Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 161. Novartis Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 162. Novo Nordisk Corporation Information
    Table 163. Novo Nordisk Description and Business Overview
    Table 164. Novo Nordisk Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Novo Nordisk Diabetes Drugs Product
    Table 166. Novo Nordisk Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 167. Novo Nordisk Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 168. Novo Nordisk Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 169. Sanofi Corporation Information
    Table 170. Sanofi Description and Business Overview
    Table 171. Sanofi Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 172. Sanofi Diabetes Drugs Product
    Table 173. Sanofi Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 174. Sanofi Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 175. Sanofi Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 176. SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
    Table 177. SHIJIAZHUANG YILING PHARMACEUTICAL Description and Business Overview
    Table 178. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 179. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product
    Table 180. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 181. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 182. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 183. Takeda Corporation Information
    Table 184. Takeda Description and Business Overview
    Table 185. Takeda Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 186. Takeda Diabetes Drugs Product
    Table 187. Takeda Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 188. Takeda Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 189. Takeda Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 190. Taloph Corporation Information
    Table 191. Taloph Description and Business Overview
    Table 192. Taloph Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 193. Taloph Diabetes Drugs Product
    Table 194. Taloph Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 195. Taloph Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 196. Taloph Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 197. Tianan Pharmaceutical Corporation Information
    Table 198. Tianan Pharmaceutical Description and Business Overview
    Table 199. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 200. Tianan Pharmaceutical Diabetes Drugs Product
    Table 201. Tianan Pharmaceutical Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 202. Tianan Pharmaceutical Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 203. Tianan Pharmaceutical Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 204. Tonghua DongBao Corporation Information
    Table 205. Tonghua DongBao Description and Business Overview
    Table 206. Tonghua DongBao Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 207. Tonghua DongBao Diabetes Drugs Product
    Table 208. Tonghua DongBao Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 209. Tonghua DongBao Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 210. Tonghua DongBao Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 211. Wanbang Biopharmaceuticals Corporation Information
    Table 212. Wanbang Biopharmaceuticals Description and Business Overview
    Table 213. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 214. Wanbang Biopharmaceuticals Diabetes Drugs Product
    Table 215. Wanbang Biopharmaceuticals Diabetes Drugs Sales Proportion of Diabetes Drugs by Product in 2021
    Table 216. Wanbang Biopharmaceuticals Diabetes Drugs Sales Proportion of Diabetes Drugs by Application in 2021
    Table 217. Wanbang Biopharmaceuticals Diabetes Drugs Sales Proportion of Diabetes Drugs by Geographic Area in 2021
    Table 218. Global Diabetes Drugs Sales by Type (2017-2022) & (M Units)
    Table 219. Global Diabetes Drugs Sales Forecast by Type (2023-2028) & (M Units)
    Table 220. Global Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 221. Global Diabetes Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 222. Global Diabetes Drugs Sales by Application (2017-2022) & (M Units)
    Table 223. Global Diabetes Drugs Sales Forecast by Application (2023-2028) & (M Units)
    Table 224. Global Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 225. Global Diabetes Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 226. North America Diabetes Drugs Sales by Country (2017-2022) & (M Units)
    Table 227. North America Diabetes Drugs Sales by Country (2023-2028) & (M Units)
    Table 228. North America Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 229. North America Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 230. North America Diabetes Drugs Sales by Type (2017-2022) & (M Units)
    Table 231. North America Diabetes Drugs Sales by Application (2017-2022) & (M Units)
    Table 232. Asia-Pacific Diabetes Drugs Sales by Region (2017-2022) & (M Units)
    Table 233. Asia-Pacific Diabetes Drugs Sales by Region (2023-2028) & (M Units)
    Table 234. Asia-Pacific Diabetes Drugs Revenue by Region (2017-2028) & (US$ Million)
    Table 235. Asia-Pacific Diabetes Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 236. Asia-Pacific Diabetes Drugs Sales by Type (2017-2022) & (M Units)
    Table 237. Asia-Pacific Diabetes Drugs Sales by Application (2017-2022) & (M Units)
    Table 238. Europe Diabetes Drugs Sales by Country (2017-2022) & (M Units)
    Table 239. Europe Diabetes Drugs Sales by Country (2023-2028) & (M Units)
    Table 240. Europe Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 241. Europe Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 242. Europe Diabetes Drugs Sales by Type (2017-2022) & (M Units)
    Table 243. Europe Diabetes Drugs Sales by Application (2017-2022) & (M Units)
    Table 244. Latin America Diabetes Drugs Sales by Country (2017-2022) & (M Units)
    Table 245. Latin America Diabetes Drugs Sales by Country (2023-2028) & (M Units)
    Table 246. Latin America Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 247. Latin America Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 248. Latin America Diabetes Drugs Sales by Type (2017-2022) & (M Units)
    Table 249. Latin America Diabetes Drugs Sales by Application (2017-2022) & (M Units)
    Table 250. Middle East and Africa Diabetes Drugs Sales by Country (2017-2022) & (M Units)
    Table 251. Middle East and Africa Diabetes Drugs Sales by Country (2023-2028) & (M Units)
    Table 252. Middle East and Africa Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 253. Middle East and Africa Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 254. Middle East and Africa Diabetes Drugs Sales by Type (2017-2022) & (M Units)
    Table 255. Middle East and Africa Diabetes Drugs Sales by Application (2017-2022) & (M Units)
    Table 256. Diabetes Drugs Key Raw Materials, Industry Status and Trend
    Table 257. Diabetes Drugs Key Raw Materials and Upstream Suppliers
    Table 258. Diabetes Drugs Clients Status and Trend
    Table 259. Diabetes Drugs Typical Clients
    Table 260. Diabetes Drugs Distributors
    Table 261. Diabetes Drugs Market Trends
    Table 262. Diabetes Drugs Market Drivers
    Table 263. Diabetes Drugs Market Challenges
    Table 264. Diabetes Drugs Market Restraints
    Table 265. Research Programs/Design for This Report
    Table 266. Key Data Information from Secondary Sources
    Table 267. Key Data Information from Primary Sources
List of Figures
    Figure 1. Diabetes Drugs Product Picture
    Figure 2. Global Diabetes Drugs Sales Market Share by Type in 2021 & 2028
    Figure 3. Insulin Product Picture
    Figure 4. DPP-4 Product Picture
    Figure 5. GLP-1 Product Picture
    Figure 6. SGLT-2 Product Picture
    Figure 7. Global Diabetes Drugs Sales Market Share by Application in 2021 & 2028
    Figure 8. Type 1 Diabetes Examples
    Figure 9. Type 2 Diabetes Examples
    Figure 10. Diabetes Drugs Report Years Considered
    Figure 11. Global Diabetes Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Diabetes Drugs Market Size 2017-2028 (US$ Million)
    Figure 13. Global Diabetes Drugs Sales 2017-2028 (M Units)
    Figure 14. Global Diabetes Drugs Market Size Market Share by Region: 2022 Versus 2028
    Figure 15. Global Diabetes Drugs Sales Market Share Forecast by Region (2017-2028)
    Figure 16. Global Diabetes Drugs Revenue Market Share by Region (2017-2028)
    Figure 17. Global Diabetes Drugs Sales Share by Manufacturer in 2021
    Figure 18. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Diabetes Drugs Sales Market Share Forecast by Type (2017-2028)
    Figure 20. Global Diabetes Drugs Revenue Market Share Forecast by Type (2017-2028)
    Figure 21. Diabetes Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
    Figure 22. Global Diabetes Drugs Sales Market Share Forecast by Application (2017-2028)
    Figure 23. Global Diabetes Drugs Revenue Market Share Forecast by Application (2017-2028)
    Figure 24. Diabetes Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
    Figure 25. North America Diabetes Drugs Revenue 2017-2028 (US$ Million)
    Figure 26. North America Diabetes Drugs Sales Market Share by Type (2017-2022)
    Figure 27. North America Diabetes Drugs Sales Market Share by Application (2017-2022)
    Figure 28. Asia-Pacific Diabetes Drugs Revenue 2017-2028 (US$ Million)
    Figure 29. Asia-Pacific Diabetes Drugs Sales Market Share by Region (2017-2028)
    Figure 30. Asia-Pacific Diabetes Drugs Revenue Market Share by Region (2017-2028)
    Figure 31. Asia-Pacific Diabetes Drugs Sales Market Share by Type (2017-2022)
    Figure 32. Asia-Pacific Diabetes Drugs Sales Market Share by Application (2017-2022)
    Figure 33. Europe Diabetes Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 34. Europe Diabetes Drugs Sales Market Share by Country (2017-2028)
    Figure 35. Europe Diabetes Drugs Revenue Market Share by Country (2017-2028)
    Figure 36. Europe Diabetes Drugs Sales Market Share by Type (2017-2022)
    Figure 37. Europe Diabetes Drugs Sales Market Share by Application (2017-2022)
    Figure 38. Latin America Diabetes Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 39. Latin America Diabetes Drugs Sales Market Share by Country (2017-2028)
    Figure 40. Latin America Diabetes Drugs Revenue Market Share by Country (2017-2022)
    Figure 41. Latin America Diabetes Drugs Sales Market Share by Type (2017-2022)
    Figure 42. Latin America Diabetes Drugs Sales Market Share by Application (2017-2022)
    Figure 43. Middle East and Africa Diabetes Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 44. Middle East and Africa Diabetes Drugs Sales Market Share by Country (2017-2028)
    Figure 45. Middle East and Africa Diabetes Drugs Revenue Market Share by Country (2017-2028)
    Figure 46. Middle East and Africa Diabetes Drugs Sales Market Share by Type (2017-2022)
    Figure 47. Middle East and Africa Diabetes Drugs Sales Market Share by Application (2017-2022)
    Figure 48. Diabetes Drugs Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Diabetes Drugs Raw Materials by Region in 2021
    Figure 50. Diabetes Drugs Distribution Channels
    Figure 51. Global Diabetes Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 52. Global Diabetes Drugs Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS